By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics reported late on Wednesday a 37 percent hike in first-quarter revenues, as it trimmed its net loss.

For the three months ended March 31, the Rehovet, Israel-based molecular diagnostics firm said revenues increased to $37,000 from $27,000.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.